Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products not yet catalogued.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
No adverse media (litigation, regulator action, layoffs or financial distress) involving Elation Health found in HSH's search of the last 24 months.
No data breaches, cyber incidents or regulator actions involving Elation Health found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Primary care EHR software supplier; no regulatory or clinical safety actions found in the last 24 months.
Apr 2025: Elation Health and Seoul Medical Group announced a partnership to provide a customised EHR across SMG's primary care network. Jun 2026: Elation acquired voice AI company Aster. No contract disputes found in HSH's search of the last 24 months.
No competitors linked yet.